Treatment of mCRPC

Treatment of Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer

Bryan Mehlhaff, MD discusses the treatment history of a 49-year-old prostate cancer patient from the time of diagnosis through 2012.

Bryan A. Mehlhaff, MD
Oregon Urology Institute

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe